Gilly Biotechnologies, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Gilly Biotechnologies, Inc. - overview
Established
2025
Location
-, -, US
Primary Industry
Biotechnology
About
Based in San Francisco, California, USA, and incorporated in March 2025, Gilly Biotechnologies, Inc. operates as a venture-backed biotech company currently in stealth mode. It focuses on developing innovative solutions within the life sciences sector, supported by accelerators and early-stage investors. The company has not publicly disclosed its product portfolio, as it operates in stealth mode.
However, its positioning suggests a focus on advanced biotechnological applications, likely involving therapeutic or diagnostic innovations. Currently, Gilly Biotechnologies does not generate commercial revenue and relies on venture capital funding for operations. Its future revenue model is expected to include product commercialization and strategic partnerships in biotech markets. Gilly Biotechnologies aims to scale its operations post-stealth phase by leveraging investor networks and accelerating R&D.
Plans likely include expanding into clinical development and forming alliances to bring its innovations to market.
Current Investors
SOSV
Primary Industry
Biotechnology
Sub Industries
Biotechnology
Verticals
HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.